Dermata Therapeutics (DRMA) Q4 2025 Earnings

14NovConfirmed
Q1 2025
Q2 2025
Q3 2025
Q4 2025
-4.5
-3.45
-2.39
-1.34

Details

Expected EPS
-1.59
Actual EPS
-1.65
Surprise EPS
-0.06
Surprise Percent
+3.77%

Description

Dermata Therapeutics (DRMA) has reported earnings of -1.65 per share for Q4 2025.

0 Comments

Share your thoughts